Pancreatic Cancer Research

ResearcherEssen University HospitalActive in the last 2 years

Hideo Baba

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 6 November 2026

Matched on OpenAlex author ID A5113523976. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
47
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 3 papers · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 8

  1. Transcription factor switching drives subtype-specific pancreatic cancer. Co-author DOI 10.1038/s41588-025-02389-7↗
  2. Statins exert anti-growth effects by suppressing YAP/TAZ expressions via JNK signal activation and eliminate the immune suppression by downregulating PD-L1 exp… Last author PMID 37293171↗
  3. High Expression of Bloom Syndrome Helicase is a Key Factor for Poor Prognosis and Advanced Malignancy in Patients with Pancreatic Cancer: A Retrospective Study. Last author DOI 10.1245/s10434-022-11500-9↗
  4. Metabolic shift to serine biosynthesis through 3-PG accumulation and PHGDH induction promotes tumor growth in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2021.09.007↗
  5. Precision surgery with the genetic assessment for operable pancreatic cancer beyond the radiological assessment alone. First author DOI 10.21037/hbsn-20-820↗
  6. Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel Regimen for Borderline Resectable Pancreatic Cancer with Arterial Involvement: A Prospective Mult… Co-author DOI 10.29337/ijsp.142↗
  7. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases. Co-author DOI 10.1053/j.gastro.2020.04.057↗
  8. Pancreatic cancer arising from the remnant pancreas after pancreatectomy: a multicenter retrospective study by the Kyushu Study Group of Clinical Cancer. Co-author DOI 10.1007/s00535-018-01535-9↗

Closest collaborators

The 25 strongest of 47 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hiromitsu Hayashi · 4 shared papers, 2021–2023 · strength 0.67
  2. Shigeki Nakagawa · 3 shared papers, 2019–2023 · strength 0.38
  3. Kosuke Mima · 2 shared papers, 2022–2023 · strength 0.30
  4. Zhao Liu · 2 shared papers, 2022–2023 · strength 0.30
  5. Tatsunori Miyata · 2 shared papers, 2021–2023 · strength 0.26
  6. Katsunori Imai · 2 shared papers, 2021–2022 · strength 0.23
  7. Masafumi Inomata · 2 shared papers, 2019–2021 · strength 0.20
  8. Kota Arima · 2 shared papers, 2019–2021 · strength 0.17
  9. Phyllis F. Cheung · 1 shared paper, 2025 · strength 0.17
  10. Barbara T. Grünwald · 1 shared paper, 2025 · strength 0.17
  11. Niklas Krebs · 1 shared paper, 2025 · strength 0.17
  12. Shalini V. Rao · 1 shared paper, 2025 · strength 0.17
  13. Jason S. Carroll · 1 shared paper, 2025 · strength 0.17
  14. Rebecca J. Brais · 1 shared paper, 2025 · strength 0.17
  15. Jens Thomas Siveke · 1 shared paper, 2025 · strength 0.17
  16. Duncan Ian Jodrell · 1 shared paper, 2025 · strength 0.17
  17. Norio Uemura · 1 shared paper, 2023 · strength 0.16
  18. Hidetoshi Nitta · 1 shared paper, 2023 · strength 0.16
  19. Kazuki Matsumura · 1 shared paper, 2023 · strength 0.16
  20. Hiroki Sato · 1 shared paper, 2023 · strength 0.16
  21. Takashi Matsumoto · 1 shared paper, 2022 · strength 0.14
  22. Chuan Lan · 1 shared paper, 2022 · strength 0.14
  23. Takayoshi Kaida · 1 shared paper, 2022 · strength 0.14
  24. Hiroaki Nagano · 1 shared paper, 2021 · strength 0.12
  25. Kazuyoshi Nishihara · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.